In present study we evaluate the mass of hepatic IPCs in rat models of T1D and T2D and discuss the role of glycaemia level, expression of pancreatic transcription factors Pdx1, MafA and Ngn3, number of oval cells, inflammation and tissue damage in emerging of hepatic IPCs in vivo. This evidence concerns the gene NEUROG3 and type 2 diabetes mellitus.